Ubs Group Ag T2 Biosystems, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.09 - $565.0 $18,986 - $119 Million
210,965 Added 10548.25%
212,965 $24,000
Q2 2022

Aug 10, 2022
SELL
$0.15 - $0.54 $255 - $918
-1,700 Reduced 45.95%
2,000 $0
Q1 2022

May 16, 2022
SELL
$0.36 - $0.57 $16,870 - $26,711
-46,863 Reduced 92.68%
3,700 $2,000
Q4 2021

Feb 14, 2022
BUY
$0.46 - $0.94 $21,556 - $44,051
46,863 Added 1266.57%
50,563 $26,000
Q3 2021

Nov 15, 2021
SELL
$0.86 - $1.21 $8,600 - $12,100
-10,000 Reduced 72.99%
3,700 $3,000
Q4 2020

Feb 11, 2021
SELL
$1.06 - $1.51 $14,887 - $21,207
-14,045 Reduced 50.62%
13,700 $17,000
Q3 2020

Nov 12, 2020
BUY
$1.15 - $2.1 $13,851 - $25,294
12,045 Added 76.72%
27,745 $38,000
Q2 2020

Jul 31, 2020
SELL
$0.48 - $1.67 $42,770 - $148,807
-89,106 Reduced 85.02%
15,700 $20,000
Q1 2020

May 01, 2020
BUY
$0.28 - $1.23 $28,309 - $124,360
101,106 Added 2732.59%
104,806 $68,000
Q4 2019

Feb 14, 2020
SELL
$0.96 - $2.94 $1,215 - $3,722
-1,266 Reduced 25.49%
3,700 $4,000
Q3 2019

Nov 14, 2019
BUY
$0.58 - $3.01 $734 - $3,810
1,266 Added 34.22%
4,966 $12,000
Q2 2019

Aug 14, 2019
SELL
$1.47 - $3.16 $5,862 - $12,602
-3,988 Reduced 51.87%
3,700 $6,000
Q1 2019

May 14, 2019
SELL
$2.56 - $4.48 $19,778 - $34,612
-7,726 Reduced 50.12%
7,688 $20,000
Q4 2018

Feb 14, 2019
SELL
$2.98 - $6.86 $11,744 - $27,035
-3,941 Reduced 20.36%
15,414 $46,000
Q3 2018

Nov 14, 2018
SELL
$5.36 - $7.83 $248,687 - $363,288
-46,397 Reduced 70.56%
19,355 $144,000
Q2 2018

Aug 14, 2018
BUY
$5.97 - $9.58 $143,256 - $229,881
23,996 Added 57.47%
65,752 $509,000
Q1 2018

May 15, 2018
BUY
$4.21 - $7.0 $151,901 - $252,567
36,081 Added 635.79%
41,756 $271,000
Q4 2017

Feb 14, 2018
BUY
$3.73 - $4.6 $18,571 - $22,903
4,979 Added 715.37%
5,675 $23,000
Q3 2017

Nov 14, 2017
BUY
$3.9 - $6.78 $2,098 - $3,647
538 Added 340.51%
696 $3,000
Q2 2017

Aug 14, 2017
SELL
N/A
-6,269 Reduced 97.54%
158 $1,000
Q1 2017

Nov 14, 2017
BUY
N/A
6,427
6,427 $34,000

About T2 Biosystems, Inc.

TTOO Quotes by TradingView
  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $15.9M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email